Rockwell Medical Inc (NASDAQ: RMTI), a biopharmaceutical company, announced yesterday that it has named Charlie Shiner as its new vice president, Marketing, effective immediately.
Shiner will report to Stuart Paul, president & chief executive officer of the company.
Shiner joins Rockwell Medical from Otsuka Pharmaceuticals Ltd. He most recently served as the marketing franchise leader for Otsuka's renal portfolio, where he successfully launched Otsuka's new therapeutic Jynarque and managed other key renal therapeutics. Previously, he held the roles of director and senior product manager, Digital Marketing at Otsuka America Pharmaceuticals. Earlier in his career, Shiner spent 11 years at Pfizer Inc where among other roles, he worked to identify and execute upon strategic opportunities for Pfizer's clinical treatments within hospital accounts across the United States.
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar